Literature DB >> 30979436

C9orf72 hexanucleotide repeat length in older population: normal variation and effects on cognition.

Karri Kaivola1, Anna Kiviharju2, Lilja Jansson2, Ville Rantalainen3, Johan G Eriksson4, Timo E Strandberg5, Hannu Laaksovirta2, Alan E Renton6, Bryan J Traynor7, Liisa Myllykangas8, Pentti J Tienari2.   

Abstract

The hexanucleotide repeat expansion in C9orf72 is a common cause of amyotrophic lateral sclerosis/frontotemporal dementia and also rarely found in other psychiatric and neurodegenerative conditions. Alleles with >30 repeats are often considered an expansion, but the pathogenic repeat length threshold is still unclear. It is also unclear whether intermediate repeat length alleles (often defined either as 7-30 or 20-30 repeats) have clinically significant effects. We determined the C9orf72 repeat length distribution in 3142 older Finns (aged 60-104 years). The longest nonexpanded allele was 45 repeats. We found 7-45 repeats in 1036/3142 (33%) individuals, 20-45 repeats in 56/3142 (1.8%), 30-45 repeats in 12/3142 (0.38%), and expansion (>45 repeats) in 6/3142 (0.19%). There was no apparent clustering of neurodegenerative or psychiatric diseases in individuals with 30-45 repeats indicating that 30-45 repeats are not pathogenic. None of the 6 expansion carriers had a diagnosis of amyotrophic lateral sclerosis/frontotemporal dementia but 4 had a diagnosis of a neurodegenerative or psychiatric disease. Intermediate length alleles (categorized as 7-45 and 20-45 repeats) did not associate with Alzheimer's disease or cognitive impairment.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; C9orf72; Cohort studies; Dementia; Genetics

Mesh:

Substances:

Year:  2019        PMID: 30979436      PMCID: PMC8981799          DOI: 10.1016/j.neurobiolaging.2019.02.026

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  36 in total

1.  Germline mutational dynamics in myotonic dystrophy type 1 males: allele length and age effects.

Authors:  L Martorell; J Gámez; M L Cayuela; F K Gould; J P McAbney; T Ashizawa; D G Monckton; M Baiget
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

2.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.

Authors:  S Purcell; S S Cherny; P C Sham
Journal:  Bioinformatics       Date:  2003-01       Impact factor: 6.937

3.  De novo expansion of a (CAG)n repeat in sporadic Huntington's disease.

Authors:  R H Myers; M E MacDonald; W J Koroshetz; M P Duyao; C M Ambrose; S A Taylor; G Barnes; J Srinidhi; C S Lin; W L Whaley
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

4.  Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population.

Authors:  L Myllykangas; T Polvikoski; R Sulkava; A Verkkoniemi; R Crook; P J Tienari; A K Pusa; L Niinistö; P O'Brien; K Kontula; J Hardy; M Haltia; J Pérez-Tur
Journal:  Ann Neurol       Date:  1999-09       Impact factor: 10.422

5.  C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment.

Authors:  Rita Cacace; Caroline Van Cauwenberghe; Karolien Bettens; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Mathieu Vandenbulcke; Jasper Van Dongen; Veerle Bäumer; Lubina Dillen; Maria Mattheijssens; Karin Peeters; Marc Cruts; Rik Vandenberghe; Peter P De Deyn; Christine Van Broeckhoven; Kristel Sleegers
Journal:  Neurobiol Aging       Date:  2013-01-24       Impact factor: 4.673

6.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

7.  Patterns of growth among children who later develop type 2 diabetes or its risk factors.

Authors:  J G Eriksson; C Osmond; E Kajantie; T J Forsén; D J P Barker
Journal:  Diabetologia       Date:  2006-10-03       Impact factor: 10.122

8.  Analysis of the hexanucleotide repeat expansion and founder haplotype at C9ORF72 in an Irish psychosis case-control sample.

Authors:  Ciara Fahey; Susan Byrne; Russell McLaughlin; Kevin Kenna; Aleksey Shatunov; Gary Donohoe; Michael Gill; Ammar Al-Chalabi; Daniel G Bradley; Orla Hardiman; Aiden P Corvin; Derek W Morris
Journal:  Neurobiol Aging       Date:  2013-12-12       Impact factor: 4.673

9.  The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.

Authors:  I Gijselinck; S Van Mossevelde; J van der Zee; A Sieben; S Engelborghs; J De Bleecker; A Ivanoiu; O Deryck; D Edbauer; M Zhang; B Heeman; V Bäumer; M Van den Broeck; M Mattheijssens; K Peeters; E Rogaeva; P De Jonghe; P Cras; J-J Martin; P P de Deyn; M Cruts; C Van Broeckhoven
Journal:  Mol Psychiatry       Date:  2015-10-20       Impact factor: 15.992

10.  C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease.

Authors:  Karen Nuytemans; Güney Bademci; Martin M Kohli; Gary W Beecham; Liyong Wang; Juan I Young; Fatta Nahab; Eden R Martin; John R Gilbert; Michael Benatar; Jonathan L Haines; William K Scott; Stephan Züchner; Margaret A Pericak-Vance; Jeffery M Vance
Journal:  Ann Hum Genet       Date:  2013-07-12       Impact factor: 1.670

View more
  3 in total

1.  Genome-wide association study of frontotemporal dementia identifies a C9ORF72 haplotype with a median of 12-G4C2 repeats that predisposes to pathological repeat expansions.

Authors:  Lianne M Reus; Iris E Jansen; Merel O Mol; Fred van Ruissen; Jeroen van Rooij; Natasja M van Schoor; Niccolò Tesi; Marcel J T Reinders; Martijn A Huisman; Henne Holstege; Pieter Jelle Visser; Sterre C M de Boer; Marc Hulsman; Shahzad Ahmad; Najaf Amin; Andre G Uitterlinden; Arfan Ikram; Cornelia M van Duijn; Harro Seelaar; Inez H G B Ramakers; Frans R J Verhey; Aad van der Lugt; Jurgen A H R Claassen; Geert Jan Biessels; Peter Paul De Deyn; Philip Scheltens; Wiesje M van der Flier; John C van Swieten; Yolande A L Pijnenburg; Sven J van der Lee
Journal:  Transl Psychiatry       Date:  2021-09-02       Impact factor: 6.222

2.  ALS in Finland: Major Genetic Variants and Clinical Characteristics of Patients With and Without the C9orf72 Hexanucleotide Repeat Expansion.

Authors:  Hannu Laaksovirta; Jyrki Launes; Lilja Jansson; Bryan J Traynor; Karri Kaivola; Pentti J Tienari
Journal:  Neurol Genet       Date:  2022-03-14

3.  An exploratory pilot study on the involvement of APOE, HFE, C9ORF72 variants and comorbidities in neurocognitive and physical performance in a group of HIV-infected people.

Authors:  Isabella Zanella; Eliana Zacchi; Chiara Fornari; Benedetta Fumarola; Melania Degli Antoni; Daniela Zizioli; Eugenia Quiros-Roldan
Journal:  Metab Brain Dis       Date:  2022-03-30       Impact factor: 3.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.